Silence Therapeutics plc (SLN) Ownership

$7.41

north_east
$0.02 (0.27%)
Day's range
$7.34
Day's range
$7.87

Silence Therapeutics plc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TCG CROSSOVER MANAGEMENT, LLC 02/14/2025 3.03 M $20.87 M   0.00% 2.16%
SIREN, L.L.C. 02/14/2025 2.83 M $19.48 M   0.00% 2.02%
REDMILE GROUP, LLC 02/14/2025 2.40 M $16.51 M   26.33% 1.71%
LOMBARD ODIER ASSET MANAGEMENT (USA) CORP 02/14/2025 1.86 M $10.20 M   -30.33% 1.32%
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 02/18/2025 1.15 M $7.90 M   0.00% 0.82%
VIVO CAPITAL, LLC 02/13/2025 1.11 M $7.61 M   0.00% 0.79%
NANTAHALA CAPITAL MANAGEMENT, LLC 02/14/2025 1.05 M $7.22 M   424.84% 0.75%
NEXTECH INVEST LTD. 02/14/2025 952,400 $6.55 M   0.00% 0.68%
EVENTIDE ASSET MANAGEMENT, LLC 02/14/2025 640,000 $4.40 M   0.00% 0.46%
POINT72 ASSET MANAGEMENT, L.P. 02/14/2025 633,100 $4.36 M   35.34% 0.45%
CANTOR FITZGERALD, L. P. 02/14/2025 539,726 $3.71 M   61.50% 0.38%
WOODLINE PARTNERS LP 02/14/2025 498,732 $3.43 M   22.57% 0.36%
PARKMAN HEALTHCARE PARTNERS LLC 02/14/2025 491,080 $3.38 M   -1.36% 0.35%
MARSHALL WACE, LLP 02/13/2025 488,889 $3.36 M   190.28% 0.35%
5AM VENTURE MANAGEMENT, LLC 02/14/2025 476,200 $3.28 M   0.00% 0.34%
MILLENNIUM MANAGEMENT LLC 02/14/2025 473,552 $3.26 M   -57.35% 0.34%
SATURN V CAPITAL MANAGEMENT LLC 02/14/2025 395,024 $2.72 M   -17.90% 0.28%
AQUILO CAPITAL MANAGEMENT, LLC 02/14/2025 367,214 $2.53 M   15.76% 0.26%
UBS GROUP AG 02/14/2025 356,071 $2.45 M   403.91% 0.25%
BOOTHBAY FUND MANAGEMENT, LLC 02/14/2025 351,527 $2.42 M   105.39% 0.25%
BLACKROCK FUNDING, INC. /DE 02/07/2025 211,507 $1.46 M   100.00% 0.15%
INTEGRAL HEALTH ASSET MANAGEMENT, LLC 02/14/2025 200,000 $1.38 M   100.00% 0.14%
M28 CAPITAL MANAGEMENT LP 02/13/2025 185,100 $1.27 M   0.00% 0.13%
HSBC HOLDINGS PLC 02/14/2025 172,834 $1.19 M   -2.81% 0.12%
TWO SIGMA INVESTMENTS, LP 02/14/2025 142,052 $977,318   -16.14% 0.10%
UBS OCONNOR LLC 02/14/2025 128,990 $887,451   50.51% 0.09%
SCHONFELD STRATEGIC ADVISORS LLC 02/14/2025 123,200 $847,616   -25.78% 0.09%
CUBIST SYSTEMATIC STRATEGIES, LLC 02/14/2025 106,320 $731,482   129.61% 0.08%
TWO SIGMA ADVISERS, LP 02/14/2025 98,800 $679,744   18.61% 0.07%
BANK OF MONTREAL /CAN/ 02/13/2025 65,007 $447,248   -0.39% 0.05%
TREXQUANT INVESTMENT LP 02/12/2025 63,663 $438,001   100.00% 0.05%
CITIGROUP INC 02/12/2025 60,502 $416,254   3.72% 0.04%
QUBE RESEARCH & TECHNOLOGIES LTD 02/14/2025 54,746 $376,652   185.19% 0.04%
GOLDMAN SACHS GROUP INC 02/11/2025 36,885 $253,769   20.41% 0.03%
WALLEYE CAPITAL LLC 02/13/2025 36,397 $250,411   100.00% 0.03%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 29,417 $202,388   0.00% 0.02%
VERITION FUND MANAGEMENT LLC 02/14/2025 24,123 $165,966   111.79% 0.02%
Y-INTERCEPT (HONG KONG) LTD 02/04/2025 21,217 $145,973   0.66% 0.02%
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS 02/11/2025 19,467 $133,933   100.00% 0.01%
ACADIAN ASSET MANAGEMENT LLC 02/11/2025 19,467 $133,000   100.00% 0.01%
RATHBONES GROUP PLC 02/13/2025 18,421 $126,736   0.00% 0.01%
ADAR1 CAPITAL MANAGEMENT, LLC 02/13/2025 18,000 $123,840   -55.32% 0.01%
FNY INVESTMENT ADVISERS, LLC 01/13/2025 17,515 $120,000   100.00% 0.01%
AMERIPRISE FINANCIAL INC 02/14/2025 16,360 $112,557   100.00% 0.01%
ADVISOR GROUP HOLDINGS, INC. 02/07/2025 13,159 $239,083   0.00% 0.01%
CUSTOM INDEX SYSTEMS, LLC 01/23/2025 11,861 $81,604   -17.72% 0.01%
VIRTUS ETF ADVISERS LLC 02/14/2025 10,772 $74,111   130.47% 0.01%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 01/24/2025 9,963 $68,545   100.00% 0.01%
BARCLAYS PLC 02/13/2025 6,126 $42,000   83.80% 0.00%
GAMMA INVESTING LLC 01/03/2025 6,092 $41,913   609.20% 0.00%

Silence Therapeutics plc institutional Ownership - FAQ's

During the previous two years, 81 institutional investors and hedge funds held shares of Silence Therapeutics plc. The most heavily invested institutionals were:

TCG Crossover Management, LLC: 3.03 M

Siren, L.L.C.: 2.83 M

Redmile Group, LLC: 2.4 M

Lombard Odier Asset Management (USA) Corp: 1.86 M

Frazier Life Sciences Management, L.P.: 1.15 M

Vivo Capital, LLC: 1.11 M

17.68% of Silence Therapeutics plc stock is owned by institutional investors.

Institutional investors have bought a total of 23.19 M shares in the last 24 months. This purchase volume represents approximately $171.80 M in transactions.